McKesson Corporation Acquires Controlling Interest in Core Ventures
June 3, 2025
McKesson Corporation completed the acquisition of an approximate 70% controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures) for about $2.49 billion. The venture was established by Florida Cancer Specialists & Research Institute (FCS), whose physicians retained an approximate 30% interest; FCS remains independently owned and joins McKesson's The US Oncology Network to strengthen community-based oncology care and expand access to clinical development and local cancer services.
- Buyers
- McKesson Corporation
- Targets
- Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures)
- Sellers
- Florida Cancer Specialists & Research Institute (FCS) / FCS physicians
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
NovaQuest Private Equity Acquires CoreRx, Inc.
January 19, 2021
Pharmaceuticals
NovaQuest Private Equity acquired CoreRx, Inc., a Clearwater, Florida–based contract development and manufacturing organization (CDMO). Affiliates of Signet Healthcare Partners will retain a minority stake; Goldman Sachs Specialty Lending Group provided debt financing. NovaQuest said the investment will support continued growth and capability expansion of CoreRx's clinical and commercial CDMO services.
-
Arsenal Capital Partners Acquires Majority Stake in OncoHealth; McKesson Makes Strategic Investment
May 9, 2022
Healthcare Services
Arsenal Capital Partners has acquired a majority ownership stake in OncoHealth, a digital health company focused on oncology, with McKesson Corporation making a strategic minority investment. Baird Capital, the prior investor, will retain a minority equity stake; financial terms were not disclosed. The investments are intended to accelerate OncoHealth’s product innovation, expansion of oncology digital solutions, and market growth.
-
CoreRx, Inc. Acquires Societal CDMO, Inc.
April 8, 2024
Pharmaceuticals
CoreRx, Inc. completed its acquisition of Societal CDMO, Inc. through a tender offer and subsequent short-form merger, acquiring approximately 92.8% of outstanding shares at $1.10 per share. Societal CDMO is now a wholly owned subsidiary of CoreRx and its common stock will be delisted from the Nasdaq Capital Market.
-
KKR to Acquire Controlling Stake in Healthcare Global Enterprises (HCG) From CVC
February 24, 2025
Healthcare Services
KKR will acquire up to a 54% controlling stake in Healthcare Global Enterprises (HCG), India’s largest oncology hospital chain, from CVC Asia V through definitive agreements. Following the transaction and an SEBI-mandated open offer, KKR is expected to hold between 54% and 77% equity, with Dr. BS Ajai Kumar remaining as non-executive chairman.
-
McKesson Acquires Controlling Interest in PRISM Vision Holdings
April 8, 2025
Healthcare Services
McKesson Corporation completed the acquisition of an approximate 80% controlling interest in PRISM Vision Holdings, LLC for about $850 million. PRISM physicians will retain an approximate 20% interest, and PRISM Vision will be consolidated within McKesson’s U.S. Pharmaceutical segment.
-
Ovation Healthcare (Grant Avenue-backed) Acquires MedCo Services
March 21, 2023
Healthcare Services
Ovation Healthcare (fka QHR Health), a hospital management and consulting company backed by Grant Avenue Capital, has acquired MedCo Services. The undisclosed deal expands Ovation’s revenue cycle management (RCM) capabilities, adds MedCo’s acute-care hospital clients and internally developed workflow software, and diversifies Ovation’s RCM technology and service offering.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.